Woodline Partners LP

Position in ZTS — Zoetis Inc.

CIK 1784547 San Francisco, CA

Position in ZTS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,720,615

-$311,533 QoQ

Shares Held

23,944

+39.3% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#513

of 1,408 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Woodline Partners LP holds $232,519,537 across 16 Drug Manufacturers - Specialty & Generic names. ZTS ranks #13 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TEVA	Teva Pharmaceutical Industries Ltd	1,189,584	$40,303,105
2	ELAN	Elanco Animal Health Inc	1,612,986	$39,695,585
3	SUPN	Supernus Pharmaceuticals, Inc.	708,276	$32,941,916
4	ALKS	Alkermes plc.	560,282	$29,358,776
5	PBH	Prestige Consumer Healthcare Inc.	359,721	$17,004,011
6	AMLX	Amylyx Pharmaceuticals, Inc.	846,387	$15,201,110
7	VTRS	Viatris Inc	803,143	$12,753,910
8	UTHR	UNITED THERAPEUTICS Corp	23,074	$12,502,185

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,720,615	23,944	+39.3%	Shares	Sole	2026-08-14
2026-03-31	$2,032,148	17,191	+112.0%	Shares	Sole	2026-05-15
2025-12-31	$1,020,148	8,108	-78.6%	Shares	Sole	2026-02-17
2025-03-31	$6,229,038	37,832	+120.6%	Shares	Sole	2025-05-15
2024-12-31	$2,793,923	17,148	-90.3%	Shares	Sole	2025-02-14
2024-09-30	$34,688,155	177,542	-6.7%	Shares	Sole	2024-11-14
2024-03-31	$32,188,818	190,230	+4.1%	Shares	Sole	2024-05-15
2022-09-30	$27,087,986	182,669	+209.3%	Shares	Sole	2022-11-14
2020-09-30	$9,766,256	59,057	-77.7%	Shares	Sole	2020-11-16
2020-06-30	$36,317,792	265,016	+305.1%	Shares	Sole	2020-08-14
2020-03-31	$7,699,632	65,423	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.